Authors: Creutzig, U Ritter, J Zimmermann, M Reinhardt, D Hermann, J Berthold, F Henze, G Jurgens, H Kabisch, H Havers, W Reiter, A Kluba, U Niggli, F Gadner, H

Citation: U. Creutzig et al., Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93, J CL ONCOL, 19(10), 2001, pp. 2705-2713

Authors: Murmann, OV Niggli, F Schafer, BW

Citation: Ov. Murmann et al., Cloning and characterization of the human PAX7 promoter, BIOL CHEM, 381(4), 2000, pp. 331-335

Authors: Huisman, TAGM Brandner, S Niggli, F Kacl, G Willi, UV Martin, E

Citation: Tagm. Huisman et al., Meningeal hemangiopericytoma in childhood, EUR RADIOL, 10(7), 2000, pp. 1073-1075

Authors: Huisman, TAGM Brandner, S Niggli, F Betts, DR Boltshauser, E Martin, E

Citation: Tagm. Huisman et al., Malignant rhabdoid tumor of the brain: Quantitative H-1 MR-spectroscopy and cytogenetics, NEUROPEDIAT, 31(3), 2000, pp. 159-161

Authors: Koesters, R Ridder, R Kopp-Schneider, A Betts, D Adams, V Niggli, F Briner, J Doeberitz, MV

Citation: R. Koesters et al., Mutational activation of the beta-catenin proto-oncogene is a common eventin the development of Wilms' tumors, CANCER RES, 59(16), 1999, pp. 3880-3882